BusinessAchillion Announces Clinical Milestone for the Advancement of JNJ-4178 in Phase 2B Development for Chronic HCVBy Nasdaq OMXDec 28, 2016, 11:05 AM UTC
BusinessAchillion Reports 2015 Fourth Quarter and Year-End Financial ResultsBy Nasdaq OMXFeb 25, 2016, 11:05 AM UTC
